| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| CYRDANAX 20 mg/ml | DEXRAZOXANUM | PULB. PT. SOL. PERF. | V03AF02 | W59811001 | PHARMASELECT INTERNATIONAL BETEILIGUNGS GMBH - AUSTRIA | ||||||
| CYRDANAX 20 mg/ml | DEXRAZOXANUM | PULB. PT. SOL. PERF. | V03AF02 | W59811002 | PHARMASELECT INTERNATIONAL BETEILIGUNGS GMBH - AUSTRIA | ||||||
| CYRDANAX 20 mg/ml | DEXRAZOXANUM | PULB. PT. SOL. PERF. | V03AF02 | W59811003 | PHARMASELECT INTERNATIONAL BETEILIGUNGS GMBH - AUSTRIA | ||||||
| CYRDANAX 20 mg/ml | DEXRAZOXANUM | PULB. PT. SOL. PERF. | V03AF02 | W59811004 | PHARMASELECT INTERNATIONAL BETEILIGUNGS GMBH - AUSTRIA | ||||||
| CYSTADANE 1g | BETAINUM ANHYDROUS | PULBERE ORALA | A16AA06 | W51849001 | ORPHAN EUROPE SARL - FRANTA | X | |||||
| CYSTINOL 265 mg | PLANTE (ARCTOSTAPHYLOS UVA-URSI) | DRAJ. | G04BX | W67607001 | SCHAPER&BRÜMMER GMBH & CO. KG - GERMANIA | ||||||
| CYSTINOL 265 mg | PLANTE (ARCTOSTAPHYLOS UVA-URSI) | DRAJ. | G04BX | W67607002 | SCHAPER&BRÜMMER GMBH & CO. KG - GERMANIA | ||||||
| CYTOTECT CP BIOTEST 100 U/ml | IMUNOGLOBULINA UMANA ANTI-CITOMEGALOVIRUS | SOL. PERF. | J06BB09 | W69368001 | BIOTEST PHARMA GMBH - GERMANIA | ||||||
| CYTOTECT CP BIOTEST 100 U/ml | IMUNOGLOBULINA UMANA ANTI-CITOMEGALOVIRUS | SOL. PERF. | J06BB09 | W69368002 | BIOTEST PHARMA GMBH - GERMANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890001 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890002 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890003 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890004 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890005 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890006 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890007 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890008 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890009 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890010 | LABORATORIOS LICONSA, S.A. - SPANIA | ||||||
| DABIGATRAN ETEXILAT LABORATORIOS LICONSA 110 mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W70890011 | LABORATORIOS LICONSA, S.A. - SPANIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman